2,112.25
-97.20
(-4.40%)
At close: January 10 at 3:29:34 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
1,064,500.00
943,600.00
908,200.00
647,500.00
582,700.00
Investing Cash Flow
-843,400.00
-791,500.00
-1,058,100.00
-346,600.00
-79,600.00
Financing Cash Flow
-271,500.00
-203,100.00
-171,200.00
-135,100.00
-104,900.00
End Cash Position
172,800.00
197,200.00
248,200.00
569,400.00
403,600.00
Capital Expenditure
-620,700.00
-692,300.00
-327,300.00
-239,500.00
-85,100.00
Repayment of Debt
-2,100.00
--
-2,700.00
-4,200.00
-90,700.00
Free Cash Flow
443,800.00
251,300.00
580,900.00
408,000.00
497,600.00
3/31/2021 - 8/12/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INDOCO.NS Indoco Remedies Limited
327.80
-1.90%
THEMISMED.NS Themis Medicare Limited
260.65
-3.91%
WINDLAS.NS Windlas Biotech Limited
988.75
-2.69%
AMRUTANJAN.NS Amrutanjan Health Care Limited
702.45
-1.11%
FDC.NS FDC Limited
488.55
-0.06%
GUFICBIO.NS Gufic Biosciences Limited
468.40
+1.68%
SHILPAMED.NS Shilpa Medicare Limited
777.15
-3.91%
AKUMS.NS AKUMS DRUGS AND PHARMA L
618.25
+0.14%
SAKAR.NS Sakar Healthcare Limited
294.55
-0.05%
NOVARTIND.BO Novartis India Limited
879.60
-3.76%